Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...

Patients who took a lower dose lost more weight on average. Read more at straitstimes.com. Read more at straitstimes.com.

Eli Lilly (NYSE:LLY) recently announced positive Phase 3 trial results for orforglipron, the first oral small molecule GLP-1 ...

Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...

Approximately 15 million Americans are on a GPL-1 or better known as Ozempic, Wegovy and Zepbound but there will be upcoming changes at CVS that may make getting the drug harder and pricier. Scripta ...

Danish group lost €90bn in market capitalisation in December after preliminary results showed it missed its target ...

Sciwind Biosciences is expanding its global footprint with licensing deals and early talks for overseas development, as it ...

The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared ...

DEAR DR. ROACH: What is the recommended daily protein allowance for older adults? I am in my 70s. -- P.R.